Travere, CSL Gets Standard EU Approval for Kidney Disorder Treatment

Seeking AlphaApr 29 11:07 ET

Express News | CSL Vifor and Travere Therapeutics Announce Standard EU Approval for Filspari® in Iga Nephropathy

ReutersApr 29 02:01 ET

CSL Vifor and Travere Therapeutics Announce Standard EU Approval for FILSPARI in IgA Nephropathy

PR NewswireApr 29 02:00 ET

Earnings Preview: TVTX to Report Financial Results Post-market on May 01

Moomoo NewsApr 25 21:00 ET

Press Release: Travere Therapeutics to Report First Quarter 2025 Financial Results

Dow JonesApr 24 16:59 ET

Travere Therapeutics, Inc. (NASDAQ:TVTX) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

Simply Wall StApr 13 08:36 ET